Background: Fractional photothermolysis has become an important laser modality in management of a number of skin conditions and photoaging. The authors describe the scientific basis of fractional photothermolysis, report on most of the available devices, discuss their clinical uses and techniques, and attempt to decipher their relative efficacy. Methods: The authors reviewed as best as possible all fractional lasers currently approved by the Food and Drug Administration for distribution into the United States. Laser wavelength, means of delivery, depth of penetration, and special features were collated. Results: Nine fractional lasers were evaluated. Main differences in outcome were related to type of laser wavelength. In general, scanning technologies are faster and more precise. Deeper injuries result in more collagen remodeling. Variations in laser wavelengths, depth of injury, type of delivery system, consumables, and architecture of the fractionated laser light are important considerations when evaluating fractional lasers. Little scientific research comparing the injury, healing, and outcomes of the various fractional lasers is available. Conclusions: Fractional photothermolysis represents a breakthrough in laser treatment for a wide array of skin problems. The safety profile has been improved over conventional ablative lasers, and the range of skin types and treatment areas have been expanded. Unlike full-surface flat beam resurfacing, fractional resurfacing damages specific microtreatment zones within the target area. Nonablative fractionals do not achieve results similar to those of the fractional ablative lasers, but certain conditions may respond better to nonablative fractional treatments. More data are needed on the comparative effects of the various types of lasers and their best indications. (Plast.
T he use of light as a medical treatment has grown considerably since the initial introduction of light amplification by stimulated emission of radiation or laser. 1 Many types of laser light are now available, and indications continue to develop. Initial laser use was developed for surgery in the 1960s. Laser has since then expanded into numerous applications to treat an array of skin conditions. Lasers direct a high-energy beam of light into specific tissues. Beams of light are one color or wavelength and vary in terms of strength and the type of tissue they target. The process of directing a light source to specific area of skin to damage it is called selective photothermolysis (photo ϭ light, while thermolysis ϭ decomposition by heat).
Lasers can be broadly broken into two general categories, ablative and nonablative. Until recently, ablative lasers have been the accepted standards of care. The carbon dioxide laser with a wavelength of 10,600 nm and the erbium:YAG with a wavelength of 2940 nm are mainstays of ablative laser treatment. With each of these types of lasers, an intense burst of laser energy is delivered onto the skin. The energy heats the water in the skin and causes both the water and tissues to vaporize. With each pass of the laser, a controlled depth of skin is vaporized. In response to the injury and subsequent healing, new layers of collagen are produced. While both of these lasers can be very effective and have a firm place in laser skin rejuvenation, each can be associated with risks of infection and scarring, hypopigmentation, and unnatural alterations in the texture and sheen of the skin. Moreover, complex aftercare is required until the skin is fully healed and the prolonged erythema is resolved, which may take months. These lasers are also limited to the thicker skin of the face rather then the thinner skin of the neck and hands.
Nonablative treatments are safer than ablative but require epidermal cooling, which may reduce efficacy of the treatment. Generally, small therapeutics windows are associated with nonablative treatments, and little to no resurfacing is achieved. The Nd:YAG 1320-nm pulsed laser (e.g., Cooltouch) is an example of a nonablative laser in wide clinical use. Intense pulsed light, light heat energy, and light-emitting diodes are all examples of nonablative treatments.
Fractional resurfacing with fractional photothermolysis represents a newer class of therapy (Fig. 1) . The stratum corneum is left largely intact as thousands of microscopic wounds completely surrounded by viable tissue for rapid healing are made with a variety of laser wavelengths and delivery systems. Immediate and delayed therapeutic results are seen through a combination of epidermal coagulation for resurfacing effect and dermal denaturization for deeper remodeling. Unlike selective photothermolysis, in which the whole of the selected target area is damaged, fractional photothermolysis seeks only to damage specific zones within the target area, leaving other zones completely intact. Fractional laser techniques started out with a wavelength of 1550 nm. The concept of a fractional laser can be applied to almost any wavelength of light and can be used with both ablative laser resurfacing and nonablative laser rejuvenation. The fractional approach may achieve comparable results to fullsurface ablative lasers without the associated side effects. It is also important to point out that although fractional and selective photothermolysis are disparate concepts, they are not necessarily exclusive. For instance, the Lux1540 is fractional because of its beam geometry, and it is selective in that it targets water, which is uniformly distributed.
Fractional As mentioned above, fractional laser resurfacing first became commercially available in 2003. 2 The initial fractional laser uses an erbium-doped fiber to deliver 3000 infrared (1550 nm) laser pulses per second 2 and targets water as a chromophore. The Fraxel SR creates an array of microscopic treatment zones measuring 50 to 150 microns in densities ranging from 400 to 6400 microscopic treatment zones/cm 2 . Each microscopic treatment zones forms a column of thermally denatured collagen from the epidermis to mid-dermis. 2 In contrast to ablative lasers, fractional lasers coagulate only 20 percent of the treated skin, sparing islands of viable epidermis and untreated dermis that maintain the skin's barrier function while speeding re-epithelialization 
TYPES OF LASERS THAT PERFORM FRACTIONAL PHOTOTHERMOLYSIS
A broad array of fractional lasers have appeared on the market since the introduction of the Fraxel SR (Table 1) . 
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Herein, we will attempt to present each of the above listed lasers and their relative benefits as well as any scientific information available. There will likely be some lasers not covered (i.e., the Fraxel Fine Lines, etc.) Also, the reader will note there is a dearth of comparative data, but we will attempt to summarize comparative scientific data if available. Lastly, the authors' primary experience has been with the Fraxel devices by Solta. That is not to say the other devices are not comparable or perhaps in some cases better. Wherever possible, we have tried to highlight the relative advantages and disadvantages of each laser. In general, the critical determinant for long-term skin resurfacing results is not the degree of immediate skin tightening, but the production of new collagen--a biological process that is highly dependent upon the depth of damage. 3, 4 Fraxel SR Laser (Solta Medical, Inc.)
The Fraxel SR Laser penetrates deeply into the skin dermis with thousands of tiny microthermal treatment zones, employing a technique called fractional photothermolysis. 2 Fractional laser resurfacing leaves the surrounding tissue unaffected and intact, permitting the skin to heal much faster than if the entire area was treated at once. Thus, downtime is minimal compared with more extensive and damaging resurfacing lasers such as the carbon dioxide laser. More importantly, many of the long-term complica- Volume 124, Number 1 • Photothermolysis for Skin Rejuvenation tions seen with the carbon dioxide laser are avoided, and virtually all skin types and colors can be safely treated.
Treating the skin fractionally with patterns of microscopic laser spots, each of which is 70 to 100 m in diameter, results in a unique wound-healing process. This is aided by the fact that each laser spot (known as a microthermal zone) is surrounded by healthy tissue. Many of the stem cells and melanocytes in the papillary dermis are spared. Fractional wound healing results in both rapid re-epithelialization of the epidermis as well as collagen remodeling to depths of 400 to 700 m (Figs. 2 and 4).
Clinical studies 1,2,5 suggest that four to six treatments spaced about 1 week apart produce a gradual remodeling of dermal matrix components, firming collagen and elastin. A topical anesthetic and a blue dye, which was required with this laser, is used before treatment, which takes about 60 minutes. Laser treatment itself takes another 45 minutes. The dye was challenging to remove in patients with enlarged pores or with hyperkeratotic lesions, such as actinic keratoses, but is no longer necessary.
Side effects are generally minimal. A mild sunburn sensation occurs for approximately an hour after the treatment. The skin has a pinkish tone for 1 to 3 days (Fig. 5 ). This is a normal sign of healing. Swelling is minimal. Within 24 hours, new epidermal skin begins to emerge. This process of skin repair involves flaking and bronzing. The use of sunscreen throughout the process is absolutely Perioral wrinkles (Fig. 6 ) are most difficult to treat with this device and require four to six treatments, 2 to 4 weeks apart, depending on severity of the wrinkles. They are slow to respond and often require skin fillers. Higher energy is usually needed (12 to 15 mJ/cm 2 ; three to four passes). That said, for deeper perioral wrinkles, we generally recommend a CO 2 fractional device or CO 2 laser. For acne scarring, one must be patient and allow time for collagen remodeling (Fig. 7) .
In designing the Fraxel 1500 (Re:store) laser, Solta attempted to accomplish two goals. First, they wanted to achieve maximum efficiency in dosage control. Second, they wanted to optimize the lesion characteristics delivered. These changes enabled physicians to deliver both consistent dosage control and optimal lesion depth, resulting in a predictable treatment for every patient every time.
Fraxel Re:pair (Fractional CO 2 , Solta Medical, Inc.)
The Fraxel Re:pair is a fractionally ablative microscopic CO 2 laser with a 10,600-nm wavelength. The Re:pair approaches the efficacy of fully ablative lasers but with markedly less downtime, less risk of adverse events, and no reports of delayed hypopigmentation. A single treatment is carried out for most patients, although the treatment may be repeated 3 to 6 months later. There are 2 to 3 days of real downtime with severe erythema and oozing followed by marked redness fading to a lighter shade by day 6 or 7. Over the next month, the redness gradually fades. The primary clinical targets are wrinkle removal, skin tightening, severe photodamage, acne, and surgical scars. Whereas the Re:store Fraxel 1500 coagulates the epithelial and dermal tissue in the microthermal zone of injury, the Re:pair vaporizes the tissue centrally, leaving a rim of coagulation necrosis on the periphery of the injury and produces immediate skin tightening and wrinkle reduction (Fig. 8) . As pulse energy is increased, penetration depth also increases. As density is increased, more surface area is treated. With experience and carefully chosen parameters, varying both energy and density, one can safely treat virtually all skin types. The Re:pair delivers the deepest injury of any of the nonablative and ablative fractional lasers. Although the injury is pronounced, re-epithelialization occurs within 48 hours (Fig. 3) .
In terms of the laser itself, the laser interface is similar to that of the Fraxel 1500 Re:store. The Volume 124, Number 1 • Photothermolysis for Skin Rejuvenation cart is integrated with a smoke evacuator, which is a unique feature that is space saving and efficient. There are two tips, a 7 mm and 15 mm, the smaller being useful for the periorbita, the nose, and upper lip and the larger for the cheeks, neck, forehead, chest, and larger surface areas. The cartridge captures debris. Both the tips and cartridges require replacement, which adds some cost. Energy varies from 5 to 70 mJ and density from 5 to 70 percent. Both can be dialed in to customize treatment to the skin type and skin condition. The delivery system is thought to be faster than any other device on the market and has the deepest penetration, up to 1.6 mm. In addition, it provides a very versatile range of fractionally ablative treatments. The handpiece is a continuous motion scanning handpiece like the Fraxel 1500 Re:store laser and provides optimal, uniform delivery of energy for greater safety, speed, and efficacy. Early clinical results have been impressive (Figs. 9 and 10) .
Affirm (Cynosure, Westford, Mass.)
The Affirm is a 1440-nm Erbium:glass laser that is nonablative. It has some unique features that in essence deliver fractionated treatments to the skin surface. The unique aspect of this laser is the combined apex pulse technology, which employs diffractive elements to bend the wavelength to treat larger surface areas. The laser also delivers both high-and low-energy light to the selected treatment areas, which "fractionates" the treatment. The combined apex pulse array in the 1440-nm Nd:YAG affirm laser system was developed to combine both mechanisms in a single treatment using high fluence regions surrounded by low-level heating. This microthermal rejuvenation approach creates apices of high-fluence regions for collagen remodeling surrounded by a collagen-stimulating, low-fluence treatment zone. 
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The combined apex pulse array is a special lens construction that consists of approximately 1000 diffractive elements affecting more surface area per single pulse. The high-fluence "apices" create a pattern of coagulated columns, while the background fluence gently heats the intervening uncoagulated tissue. Histologically, the high-fluence combined apex pulse columns are limited to approximately 300 m in depth, constraining treatment to the zone of superficial photodamage. This combination of mechanisms is proposed to improve treatment efficacy, while maintaining the side effects profile of existing methods. The laser light is delivered via a stamping technology with a spot size of 300 m, which is five times the spot size relative to repair. It is delivered with a pulsed technique. The handpiece must be replaced with each treatment and is the only consumable.
Weiss and Bene 6 studied 20 subjects under an institutional review board-controlled protocol, presenting with either superficial photoaging, including facial wrinkles, and textural and/or pig- Volume 124, Number 1 • Photothermolysis for Skin Rejuvenation mentary changes or presenting with mature, white scars (including acne scars) on the face or body. Subjects were evaluated and photographed before the initiation of treatment, before each subsequent treatment, and 1 and 3 months following the final treatment. Subjects received at least three treatments at 4-week intervals. As many as six total treatments were permitted for subjects who requested additional treatments. Before treatment, the skin was cleaned and any makeup removed. Subjects were treated using the Affirm laser system at 1440-nm wavelength, 3-msec pulse duration, and 10-mm diameter combined apex pulse array. Treatment fluences range from 3 to 7 J/cm 2 and 1-to 2-Hz pulse repetition rate. Treatment areas received between one and three treatment passes, with areas of greater visual defects receiving more passes. All treatments were delivered in conjunction with only SmartCool (Cynosure, Inc., Westford, Mass.) cold-air cooling, with fan speed between 2 and 4. No additional anesthesia was required. The combined apex pulse array requires full contact with the skin for appropriate treatment. Subjects could resume normal activities immediately following treatment. Biopsies of periauricular test spots were conducted within 3 hours of treatment in those who consented to determine the acute affects of treatment.
Ninety percent of patients completed at least five treatments, with 78 percent of the subjects achieving observer graded improvements of at least 26 to 50 percent (on a quartile scale). Treatments were well tolerated with subjects reporting an average discomfort of 2.3 (moderate discomfort) on a 0 (none) to 5 (worst) scale. The combined apex pulse technology provides a denser pattern of energy distribution creating a uniform treatment. This allows treatment with fewer passes and shortens treatment time. Typical initial response to treatment was mild to moderate erythema and edema, which resolved within hours to a few days. In rare cases, the treated areas became tan or dusky 36 to 48 hours after treatment. This transient discoloration resolved within 3 weeks in affected subjects. There were no scars or hyperpigmentation or hypopigmentation observed. Histology showed that the combined apex pulse enabled 1440-nm Nd:YAG laser creates localized regions of injury with limited epidermal damage (no denudation of epidermis). Depth of treatment was limited to the zone of photoaging and self-limited to approximately 300 m in depth. According to the author, the new 1440-nm Nd: YAG with combined apex pulse technology found in the Affirm laser showed exciting new developments in nonablative devices for the treatment of wrinkles and scars. The microthermal injury combined apex pulse ability shows promise of many different ways to achieve efficacy, though it is still early in developing the best parameters. In addition, clinical applications are expanding to other scar types, wrinkles, and pigmentation. The Affirm laser has proved to be a good compromise between full ablative and previous nonablative infrared resurfacing devices.
Harmony
XL , Pixel Co 2 Omnifit (Alma Lasers, Buffalo Grove, Ill.)
The Harmony XL is a fractional 2940-nm wavelength erbium:YAG laser that is part of a platform system that offers multiple applications, including 10 distinct technologies that treat a wide array of problems ranging from vascular lesions to photoaging. The 2940-nm erbium:YAG, micro-optic lens creates 49 (7 ϫ 7) or 81 (9 ϫ 9) pixel size ablation dots on the skin with an 11 ϫ 11-mm treatment zone. The spot size is three times larger then the Fraxel Re:pair and has a fixed density of 20 percent. The Harmony XL delivers energy to a depth of 20 to 50 m when using the fractional handpiece. The pulse duration is 1, 1.5, or 2 msec. Delivery of the laser is pulsed. Maximum coverage rate ranges from 98 mm 2 /second or 121 mm 2 /second. The handpiece must be replaced for each treatment. The laser is touted as providing the patient with the effectiveness of an ablative approach with the comfort level and convenience of a nonablative treatment. The laser can safely be used on the face, neck, chest, arms, and hands.
The Pixel CO 2 Omnifit is a fractionated CO 2 adapter that can be fitted to a number of different CO 2 lasers, including CO 2 laser from Coherent, Lumenis, Sharplan, Medical Tech Co., Ltd., and others upon request. The operational mode is superpulsed, and the spot size is 10 mm. Coverage is about 15 to 20% of the treatment area. The Pixel CO 2 Omnifit may make good financial sense for those who would like to convert a preexisting CO 2 laser into a fractionated device. No studies were found comparing this solution to other fractional laser devices, which makes it difficult to assess its treatment efficacy.
PROFractional (Sciton, Inc., Palo Alto, Calif.)
The PROFractional is also a fractional 2940-nm erbium:YAG laser that employs a scanned stamping technology for delivery with a spot size of 250 m that is three times as large as the Fraxel Re:pair. The laser is delivered as a pulse. There are no
Plastic and Reconstructive Surgery • July 2009
consumables. There is a separate smoke evacuator included in the purchase price of the laser.
The combined scanning and stamping method of delivery of laser light is less painful. Penetration of the laser is thought to range from 25 to 1500 m. The density within each treatment zone can be varied from 1.5 to 60 percent.
ActiveFX and DeepFX (Lumenis, Inc., Santa Clara, Calif.)
Both the ActiveFX and DeepFX use a scanned stamping technology for laser delivery. Both use ultrapulse delivery of a 10,600 nm CO 2 , which is similar to the Fraxel Re:pair. The system injures the skin in a bridge fashion, leaving small bridges of normal skin intact. The spot size for the ActiveFX is 89 times the size of the spot size of the Fraxel Re:pair, but the spot size for the DeepFX is clinically equivalent to the Re:pair. Density ranges from 55 to 100 percent for the ActiveFX and 5 to 25 percent for the DeepFX. Energy ranges from 80 to 100 mJ for the ActiveFX and 5 to 30 mJ for the DeepFX. Depth of laser light penetration, which is an important component in the degree of injury and subsequent skin shrinkage and collagen remodeling, is from 80 to 100 m for the ActiveFX and up to 450 m for the DeepFX. Maximum coverage rate for the DeepFX is 98 mm 2 /second, which is the same as the Pixel CO 2 Omnifit but slower then the Re:pair. Cost is an important advantage of the ActiveFX in that there are no consumables necessary for the ActiveFX. Tips and lenses are necessary to purchase for the DeepFX. A separate smoke evacuator comes with both devices. One of the nice features of the ActiveFX is that the system can also be used to perform surgical incisions for blepharoplasty and brow lift as well as treat rhinophyma. The Lux 1540 nm is a fractional erbium:glass fiber laser that delivers tiny microbeams up to a depth of 1 mm. It cools the skin surface with contact and is nonablative. Some improvement in superficial wrinkles and dyschromia can be expected. The Lux 2940 is a fractional ablative, erbium:YAG laser that uses a stamping technology to deliver a wavelength of 2940 nm. It has a spot size of 100 m, which is clinically equivalent to the Re:pair. It is a pulsed delivery system with a consumable handpiece and no smoke evacuator. It penetrates to around 200 m. Impressive changes in skin texture without concern for adverse changes in pigmentation have been noted in Fitzpatrick level I to III patients. Improvement at 2 years out may be similar to that seen with ablative CO 2 according to one study. 7 Ross and Khatri 8 studied the Lux 2940 nm microfractional, ablative erbium laser for wrinkle reduction and skin resurfacing. The microfractional technology of the erbium:YAG laser (Lux2940) enables practitioners to potentially treat several-fold deeper than traditional CO 2 and erbium:YAG lasers and evoke a dramatic healing response. In their clinical studies, 8 the Lux 2940 was utilized to treat down to a depth of 250 to 300 m; however, the device is capable of treating to a depth of over 1 mm. The Lux2940 laser uses fractional photothermolysis to generate an array of microcolumns of ablation that are bordered by residual layers of tissue coagulation that permit rapid re-epithelialization of the epidermis in as little as 12 hours.
Zelickson et al. 9 studied the Lux1550 laser in comparison with the early Fraxel SR, a 1540-erbium:glass laser. The main differences were in the delivery system. These authors found the stamping technology of the Lux1550 to take longer and be less precise then the scanning technology of the Fraxel SR. In general, the outcomes were similar as would be expected because of the similar wavelengths of each device.
Practitioners using the tri-mode Lux2940 can select different pulse widths for varying amounts of adjacent thermal damage and, therefore, tailor a subject's treatment to meet the individual's expectations of results and downtime. The Lux2940, in addition to a short-pulse ablative mode, has a long-pulse coagulative mode and a dual pulse mode that combines short and long pulses. Combining the two modes allows for increased depth of ablation together with increased coagulation zones for improved hemostasis and clinical efficacy. Subjects desiring only a short downtime (2 days or less) can be treated with less energy and/or fewer passes to achieve mild improvements in wrinkles, skin texture, and tone. For those seeking more robust wrinkle reduction, the higher settings of the Lux2940 deliver deeper ablation and wider coagulation with about 3 to 5 days of downtime.
Juvia CO 2 Fractional (Ellipse, Horsholm, Denmark)
The Juvia is a fractional CO 2 laser with a wavelength of 10,600 nm. Its spot size is fairly large at 500 m, and the laser is delivered by a scanned Volume 124, Number 1 • Photothermolysis for Skin Rejuvenation stamping technique. Energy ranges from 5 to 15 mJ and penetration into the skin is shallow at 30 m. The laser is a superpulse. There is a consumable handpiece but no smoke evacuator included in the system, which is the lightest and smallest of any of the fractional lasers.
Mosaic (Lutronic USA, Princeton Junction, N.J.)
This is an erbium:glass laser that employs a microfractional technique, delivering energy of 4 to 40 mJ. They utilize a special stamping technique with the microfractional injuries are laid down in a chaotic fashion; hence, the name Controlled Chaos Technology has been used to describe their technique. This eliminates the need for multiple linear passes and the clinical disadvantages of unavoidable overlap. The Mosaic's automatic total density counter also gives precise control over all aspects of energy delivery, which is thought to result in a more uniform treatment of the target area, reduced treatments times, and more rapid healing. The advantage of the laser seems to be that using the Controlled Chaos Technology permits more rapid treatment at varying depths. Unlike traditional lasers and light-based technologies that achieve homogenous thermal damage at a particular depth, Mosaic's exclusive patented technology sprays multiple arrays of randomized microscopic laser beams to the skin. These beams selectively coagulate a small proportion of the, collimated micro-necrotic columns that reach as far down as the reticular dermis while sparing the surrounding tissue. Re-epithelialization occurs within 24 hours, and, like the Fraxel Re:store, the strateum corneum is not disrupted. Multiple treatments are usually needed to achieve improvement in certain conditions such as acne scars.
There are two modes of delivery, dynamic and static, which allow both rapid treatment (full face in 15 minutes) and static mode's stamp-like approach, which is suitable for smaller treatment areas. In this mode, Mosaic has the ability to deliver 50 to 300 spots per square centimeter for virtually pain-free treatment. There is a choice of four different tip sizes, which permits treatment to be tailored to treat areas of different sizes without damage to the surrounding tissue. Consumables are pretty inexpensive.
According to the company's web site, one of the key features of the Mosaic system is its ability to track and record the total number of micronecrotic columns delivered to the skin. In conjunction with their patented Skin Sensor Tip system, which will only deliver treatment when in contact with the skin, the automatic total density counter allows for precise control over both the density and depth of the micro-necrotic columns delivered by tracking the number and site of each column. 
